Claire McCaskill actually said...

"To protect the American public, we must act to address these market failures."

"I just wanted to make sure that clearly if you are--what did you say, second? Second largest shareholder in Valeant and you want to talk about drug pricing in Congress, lobbying."

"In fact, in only one quarter between 2013 and 2015 did you report that growth was driven by volume, so price increases has, in fact, been the entree for your business, correct?"

"My only comment on the call is you sounded a little defensive on the price increase question."